Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23397760)

1.

PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.

Pauzar B, Karner I, Glavas-Obrovac L, Stefanić M, Dmitrović B.

Coll Antropol. 2012 Nov;36 Suppl 2:79-82.

PMID:
23397760
2.

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE.

Am J Surg Pathol. 2002 Aug;26(8):1016-23.

PMID:
12170088
3.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

4.

Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

Giordano TJ, Au AY, Kuick R, Thomas DG, Rhodes DR, Wilhelm KG Jr, Vinco M, Misek DE, Sanders D, Zhu Z, Ciampi R, Hanash S, Chinnaiyan A, Clifton-Bligh RJ, Robinson BG, Nikiforov YE, Koenig RJ.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1983-93.

5.

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.

Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J.

Endocr Relat Cancer. 2010 Jun 3;17(3):599-610. doi: 10.1677/ERC-09-0069. Print 2010 Sep.

6.

Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Lacroix L, Lazar V, Michiels S, Ripoche H, Dessen P, Talbot M, Caillou B, Levillain JP, Schlumberger M, Bidart JM.

Am J Pathol. 2005 Jul;167(1):223-31.

7.

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

Castro P, Rebocho AP, Soares RJ, Magalhães J, Roque L, Trovisco V, Vieira de Castro I, Cardoso-de-Oliveira M, Fonseca E, Soares P, Sobrinho-Simões M.

J Clin Endocrinol Metab. 2006 Jan;91(1):213-20. Epub 2005 Oct 11.

PMID:
16219715
8.

Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Algeciras-Schimnich A, Milosevic D, McIver B, Flynn H, Reddi HV, Eberhardt NL, Grebe SK.

Clin Chem. 2010 Mar;56(3):391-8. doi: 10.1373/clinchem.2009.134015. Epub 2010 Jan 7.

9.

Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.

Boos LA, Dettmer M, Schmitt A, Rudolph T, Steinert H, Moch H, Sobrinho-Simões M, Komminoth P, Perren A.

Histopathology. 2013 Aug;63(2):234-41. doi: 10.1111/his.12150. Epub 2013 Jun 6.

PMID:
23738683
10.

Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.

Marques AR, Espadinha C, Frias MJ, Roque L, Catarino AL, Sobrinho LG, Leite V.

Br J Cancer. 2004 Aug 16;91(4):732-8.

11.

A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.

Castro P, Roque L, Magalhães J, Sobrinho-Simões M.

Int J Surg Pathol. 2005 Jul;13(3):235-8.

PMID:
16086077
12.

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, Clifton-Bligh R, Robinson BG, Lui WO, Zedenius J, Larsson C.

J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9. Epub 2005 Dec 13.

PMID:
16352687
13.

Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.

Klemke M, Drieschner N, Belge G, Burchardt K, Junker K, Bullerdiek J.

Genes Chromosomes Cancer. 2012 Apr;51(4):402-8. doi: 10.1002/gcc.21925. Epub 2011 Dec 16.

PMID:
22179975
14.

Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?

Hibi Y, Nagaya T, Kambe F, Imai T, Funahashi H, Nakao A, Seo H.

Endocr J. 2004 Jun;51(3):361-6.

15.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

16.

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG.

J Clin Endocrinol Metab. 2003 Jan;88(1):354-7.

PMID:
12519876
17.

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

Marques AR, Espadinha C, Catarino AL, Moniz S, Pereira T, Sobrinho LG, Leite V.

J Clin Endocrinol Metab. 2002 Aug;87(8):3947-52.

PMID:
12161538
18.

Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.

Banito A, Pinto AE, Espadinha C, Marques AR, Leite V.

Clin Endocrinol (Oxf). 2007 Nov;67(5):706-11. Epub 2007 Jul 25.

PMID:
17651453
19.

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG, Nikiforov YE.

J Clin Endocrinol Metab. 2003 May;88(5):2318-26.

PMID:
12727991
20.

Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.

Chia WK, Sharifah NA, Reena RM, Zubaidah Z, Clarence-Ko CH, Rohaizak M, Naqiyah I, Srijit D, Hisham AN, Asmiati A, Rafie MK.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):7-13. doi: 10.1016/j.cancergencyto.2009.08.001.

PMID:
19963130
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk